Burixafor is an investigational small molecule that blocks CXCL12 binding to CXCR4 receptors on HPCs, rapidly mobilizing these cells from the bone marrow into the peripheral blood. In preclinical ...
Exicure (XCUR) announced results from its completed Phase 2 trial evaluating burixafor in combination with propranolol and granulocyte colony-stimulating factor for the mobilization of hematopoietic ...
Money Talks News on MSN
Heart pills become women's secret weapon for anxiety
Celebrity endorsements drive propranolol trend among women seeking non-addictive anxiety relief, though FDA hasn't approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback